The WHO is poised to activate its last-resort alarm for the growing mpox outbreak in central Africa by declaring it a Public Health Emergency of
Hodgkin’s lymphoma (HL), impacting the lymph nodes and lymphatic system, has experienced a gradual increase in survival rates thanks to contemporary chemotherapy.
Researchers from the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital have found more than an estimated 8,000
The field of non-pharmacological interventions for the treatment of individuals with Parkinson’s disease (PD) is reaching maturity and has the potential to substantially improve patient
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Baxter has agreed to sell
Dive Brief: Medtronic said Monday it received Food and Drug Administration approval for deep brain stimulation (DBS) technology that is implanted while the patient is
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced
VANCOUVER, BC, Aug. 13, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today
Researchers have established a suite of parameters that can be determined using ultrasound to quantitatively measure different physical characteristics of the lung.
NEW YORK and BERLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of